Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté
NCT ID: NCT02852993
Last Updated: 2016-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16099 participants
OBSERVATIONAL
2013-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to study the impact of donor and RBC characteristics on patient survival.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion
NCT06494293
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
NCT00135291
Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac Surgery
NCT00809393
French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients
NCT03313583
The Effect of Red Blood Cells Transfusion in Trauma Patients
NCT01746953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transfused patients
A cohort of patients receiving erythrocyte transfusion for the first time at the CHU Besançon or CHU Dijon during the study period.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Erythrocyte Transfusion between 2007 and 2011
* Performed at the University Hospital of Besançon or Dijon
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Etablissement Français du Sang
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxime Desmarets, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre d'Investigation Clinique; CHU Besançon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'Investigation Clinique, CHU de Besançon
Besançon, , France
Département d'information Médicale, CHU Dijon
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Desmarets M, Bardiaux L, Benzenine E, Dussaucy A, Binda D, Tiberghien P, Quantin C, Monnet E. Effect of storage time and donor sex of transfused red blood cells on 1-year survival in patients undergoing cardiac surgery: an observational study. Transfusion. 2016 May;56(5):1213-22. doi: 10.1111/trf.13537. Epub 2016 Mar 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2013/176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.